Mikhail Blagosklonny Research On Preventing Aging

Early Life and Education

Mikhail Blagosklonny is an oncologist and a scientist famously known for his contribution in studying cancer and aging. In his field of professionalism, Mikhail is a proud holder of an M.D in Internal Medicine and a Ph.D. in Experimental Medicine and Cardiology. Mikhail earned his degrees from the First Pavlov State Medical University of St. Petersburg in Russia.

Professional Contribution and Research

Rejuvenating Immunity is an article written by Mikhail where he tries to explain how the use of Rapamycin can prevent aging. Based on his argument, Mikhail explains that hyperfunction theory of aging is the continued growth that is primarily driven by signaling pathways such as Target of Rapamycin. Therefore, Mikhail believes that aging can be controlled by targeting this pathway. Visit classroomvoices.org to read more about Mikhail.

In the previous years, Rapamycin was only a basic antibiotic that was only used in controlling cancerous cells and preventing graft rejection in individuals who had undergone transplantation. However, in the current medicine world and thanks to advanced technology, Rapamycin use has evolved. For instance, Evirolimus, a class of Rapamycin has been found to improve immunity in aging individuals.

In preventing aging, Mikhail uses two different theories in explaining the use of Rapamycin. These models are Triumph of Mtor-Centric Model and Tor-Centric Model. In this article, Mikhail also addresses the issue of dying. Since Rapamycin is believed to prevent aging, many questions on whether people will die when they use Rapamycin have been raised. Mikhail explains that though Rapamycin delays the onset of age-related diseases such as cancer, the use of this drug does not make anyone immortal. Mikhail believes that in the future, the post-aging syndrome caused by the use of Rapamycin will be the causative agent of death.

Mikhail joined the New York Medicine College in the year 2002 as an associate professor of medicine and later acceded to the Ordway Research Institute in Albany as a senior scientist. In the year 2009, Mikhail joined the Roswell Park Cancer Institute as a professor of oncology. It is from this cancer center that Mikhail has gained global recognition thanks to his research skills and medical contribution.

Mikhail works as an editor-in-chief of Oncotarget and Cell Cycle. Apart from this, he also doubles up as an associate editor of cancer biology and therapy, and he is also an editorial member of the Cell Death Differential board. As a scientist with a rich history in cancer medicine, Mikhail Blagosklonny proposed the use of Rapamycin to reduce aging. Rapamycin is an antibiotic used to treat cancer. By recommending its use in prolonging life, Mikhail attributes his research to signal transduction, tumor suppression, and ontogenesis. By promoting the use of Rapamycin, Mikhail believes that cancer can be cured and aging can be controlled. By bringing all of these into one place, Mikhail believes that it is possible to prevent aging if the right procedures as stipulated by his research are followed keenly and applied accordingly.

Know more: https://www.crunchbase.com/person/mikhail-blagosklonny

Apart from conducting research, Mikhail is also an author with his main writing topics been aging hyperfunction theory. Apart from this, Mikhail also writes about chemotherapeutic engineering and cyclotheraphy. With over 300 research articles, reviews, and book chapters under his name, Mikhail is no doubt a force to reckon with when it comes to cancer research and oncology studies.

Leave a Reply

Your email address will not be published. Required fields are marked *